Literature DB >> 25594381

Protein lysine acetylation by p300/CBP.

Beverley M Dancy1, Philip A Cole1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25594381      PMCID: PMC4378506          DOI: 10.1021/cr500452k

Source DB:  PubMed          Journal:  Chem Rev        ISSN: 0009-2665            Impact factor:   60.622


× No keyword cloud information.
  406 in total

1.  Genetically encoded fluorescent reporters of protein tyrosine kinase activities in living cells.

Authors:  A Y Ting; K H Kain; R L Klemke; R Y Tsien
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

2.  The kinetics of enzyme-catalyzed reactions with two or more substrates or products. I. Nomenclature and rate equations.

Authors:  W W CLELAND
Journal:  Biochim Biophys Acta       Date:  1963-01-08

Review 3.  Codrug: an efficient approach for drug optimization.

Authors:  N Das; M Dhanawat; B Dash; R C Nagarwal; S K Shrivastava
Journal:  Eur J Pharm Sci       Date:  2010-10-01       Impact factor: 4.384

4.  CtBP represses p300-mediated transcriptional activation by direct association with its bromodomain.

Authors:  Jae-Hwan Kim; Eun-Jung Cho; Seong-Tae Kim; Hong-Duk Youn
Journal:  Nat Struct Mol Biol       Date:  2005-04-17       Impact factor: 15.369

5.  Green tea constituent (--)-epigallocatechin-3-gallate inhibits topoisomerase I activity in human colon carcinoma cells.

Authors:  S J Berger; S Gupta; C A Belfi; D M Gosky; H Mukhtar
Journal:  Biochem Biophys Res Commun       Date:  2001-10-19       Impact factor: 3.575

6.  Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma.

Authors:  M J Reginato; S L Krakow; S T Bailey; M A Lazar
Journal:  J Biol Chem       Date:  1998-01-23       Impact factor: 5.157

7.  MYST protein acetyltransferase activity requires active site lysine autoacetylation.

Authors:  Hua Yuan; Dorine Rossetto; Hestia Mellert; Weiwei Dang; Madhusudan Srinivasan; Jamel Johnson; Santosh Hodawadekar; Emily C Ding; Kaye Speicher; Nebiyu Abshiru; Rocco Perry; Jiang Wu; Chao Yang; Y George Zheng; David W Speicher; Pierre Thibault; Alain Verreault; F Bradley Johnson; Shelley L Berger; Rolf Sternglanz; Steven B McMahon; Jacques Côté; Ronen Marmorstein
Journal:  EMBO J       Date:  2011-10-21       Impact factor: 11.598

Review 8.  Curcumin as "Curecumin": from kitchen to clinic.

Authors:  Ajay Goel; Ajaikumar B Kunnumakkara; Bharat B Aggarwal
Journal:  Biochem Pharmacol       Date:  2007-08-19       Impact factor: 5.858

9.  Bromodomain and extra-terminal (BET) bromodomain inhibition activate transcription via transient release of positive transcription elongation factor b (P-TEFb) from 7SK small nuclear ribonucleoprotein.

Authors:  Koen Bartholomeeusen; Yanhui Xiang; Koh Fujinaga; B Matija Peterlin
Journal:  J Biol Chem       Date:  2012-09-05       Impact factor: 5.157

10.  Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia.

Authors:  Mark A Dawson; Rab K Prinjha; Antje Dittmann; George Giotopoulos; Marcus Bantscheff; Wai-In Chan; Samuel C Robson; Chun-wa Chung; Carsten Hopf; Mikhail M Savitski; Carola Huthmacher; Emma Gudgin; Dave Lugo; Soren Beinke; Trevor D Chapman; Emma J Roberts; Peter E Soden; Kurt R Auger; Olivier Mirguet; Konstanze Doehner; Ruud Delwel; Alan K Burnett; Phillip Jeffrey; Gerard Drewes; Kevin Lee; Brian J P Huntly; Tony Kouzarides
Journal:  Nature       Date:  2011-10-02       Impact factor: 49.962

View more
  155 in total

1.  p300 is not required for metabolic adaptation to endurance exercise training.

Authors:  Samuel A LaBarge; Christopher W Migdal; Elisa H Buckner; Hiroshi Okuno; Ilya Gertsman; Ben Stocks; Bruce A Barshop; Sarah R Nalbandian; Andrew Philp; Carrie E McCurdy; Simon Schenk
Journal:  FASEB J       Date:  2015-12-28       Impact factor: 5.191

2.  Discovery of CPI-1612: A Potent, Selective, and Orally Bioavailable EP300/CBP Histone Acetyltransferase Inhibitor.

Authors:  Jonathan E Wilson; Gaurav Patel; Chirag Patel; Francois Brucelle; Annissa Huhn; Anna S Gardberg; Florence Poy; Nico Cantone; Archana Bommi-Reddy; Robert J Sims; Richard T Cummings; Julian R Levell
Journal:  ACS Med Chem Lett       Date:  2020-04-23       Impact factor: 4.345

3.  Chemical Control of a CRISPR-Cas9 Acetyltransferase.

Authors:  Jonathan H Shrimp; Carissa Grose; Stephanie R T Widmeyer; Abigail L Thorpe; Ajit Jadhav; Jordan L Meier
Journal:  ACS Chem Biol       Date:  2018-01-17       Impact factor: 5.100

4.  Generating enzyme and radical-mediated bisubstrates as tools for investigating Gcn5-related N-acetyltransferases.

Authors:  Cory Reidl; Karolina A Majorek; Joseph Dang; David Tran; Kristen Jew; Melissa Law; Yasmine Payne; Wladek Minor; Daniel P Becker; Misty L Kuhn
Journal:  FEBS Lett       Date:  2017-08-01       Impact factor: 4.124

5.  Bisubstrate inhibitors to target histone acetyltransferase 1.

Authors:  Liza Ngo; Tyler Brown; Yujun G Zheng
Journal:  Chem Biol Drug Des       Date:  2019-01-30       Impact factor: 2.817

6.  Germline or inducible knockout of p300 or CBP in skeletal muscle does not alter insulin sensitivity.

Authors:  Vitor F Martins; Jessica R Dent; Kristoffer Svensson; Shahriar Tahvilian; Maedha Begur; Shivani Lakkaraju; Elisa H Buckner; Samuel A LaBarge; Byron Hetrick; Carrie E McCurdy; Simon Schenk
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-03-19       Impact factor: 4.310

7.  Combination Targeting of the Bromodomain and Acetyltransferase Active Site of p300/CBP.

Authors:  Beth E Zucconi; Jessica L Makofske; David J Meyers; Yousang Hwang; Mingxuan Wu; Mitzi I Kuroda; Philip A Cole
Journal:  Biochemistry       Date:  2019-04-11       Impact factor: 3.162

8.  Inhibition of p300 histone acetyltransferase activity in palate mesenchyme cells attenuates Wnt signaling via aberrant E-cadherin expression.

Authors:  Dennis R Warner; Scott C Smith; Irina A Smolenkova; M Michele Pisano; Robert M Greene
Journal:  Exp Cell Res       Date:  2016-02-24       Impact factor: 3.905

Review 9.  The Bump-and-Hole Tactic: Expanding the Scope of Chemical Genetics.

Authors:  Kabirul Islam
Journal:  Cell Chem Biol       Date:  2018-08-02       Impact factor: 8.116

10.  p300 Mediates Muscle Wasting in Lewis Lung Carcinoma.

Authors:  Thomas K Sin; James Z Zhu; Guohua Zhang; Yi-Ping Li
Journal:  Cancer Res       Date:  2019-01-31       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.